Stockreport

Capricor wins key EU designations for the lead asset [Seeking Alpha]

Capricor Therapeutics, Inc.  (CAPR) 
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF The EU drug regulator has issued orphan and ATMP designations for Capricor's ( NASDAQ: CAPR ) development work related to deramiocel in Duchenne muscular dystrophy, a m [Read more]